Anavex Life Sciences
AVXL
#7501
Rank
ยฃ0.30 B
Marketcap
ยฃ3.43
Share price
-4.28%
Change (1 day)
-54.46%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -ยฃ35.68 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ37.68 Million a decrease over its 2023 earnings that were of -ยฃ32.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ35.68 Million-5.3%
2024 -ยฃ37.68 Million14.77%
2023 -ยฃ32.83 Million-17.49%
2022 -ยฃ39.79 Million22.96%
2021 -ยฃ32.36 Million35.36%
2020 -ยฃ23.91 Million12.65%
2019 -ยฃ21.22 Million29.09%
2018 -ยฃ16.44 Million36.33%
2017 -ยฃ12.06 Million17.11%
2016 -ยฃ10.3 Million20.91%
2015 -ยฃ8.52 Million-6.29%
2014 -ยฃ9.09 Million337.28%
2013 -ยฃ2.08 Million
2008 -ยฃ3.85 Million106.01%
2007 -ยฃ1.87 Million8848.98%
2006 -ยฃ0.03 Million-79.99%
2005 -ยฃ0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ48.8 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ47.91 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.51 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ4.84 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA